MacroGenics, Inc. Alternatives & Competitors
12 companies similar to MacroGenics, Inc. — Developing immunotherapeutics to prevent autoimmune disorders, cancer and infect...
Companies similar to MacroGenics, Inc.
Xencor
Proteins by Design
Greywolf Therapeutics
We are advancing novel antigen modulation technology that controls T cells to guide the im...
NEOVACS
Nous développons les thérapies de demain et investissons dans des sociétés innovantes en B...
MabGenesis Inc.
Discovery of innovative therapeutic antibodies for human and animal health
Rival Readout
Competing with MacroGenics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ichor Biologics
Accelerating cures for infectious diseases
Novavax
Powering innovation. Protecting health.
Biotheus Inc.
To Inspire Each Other and Create Effective Medicines for Humankind
FibroGen, Inc.
Committed to being a place where our people and science thrive.
Alder Biopharmaceuticals
Dedicated to alleviating human suffering with safer and better antibody therapeutics throu...
Tavotek Biotherapeutics
Innovative Therapies. Better Health.
Abpro
Developing antibody therapies to improve the lives of patients facing severe and life-thre...
Innovent Biologics
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordina...
About MacroGenics, Inc.
MacroGenics, Inc. is at the forefront of developing immunotherapeutics aimed at combating autoimmune disorders, cancer, and infectious diseases. With a focus on next-generation antibody-based technologies, the company has built a robust pipeline of product candidates targeting cancer treatment.
Development of next-generation protein-based therapies, Clinical trials in cancer and autoimmune disorders, Partnerships with global biopharmaceutical companies
Cancer Patients, Hematology Patients, Autoimmune Disorder Patients, Biopharmaceutical Partners, Healthcare Providers
Immunotherapeutics, Autoimmune Disorders, Cancer Treatment, Infectious Diseases, Monoclonal Antibodies, Fc Engineering Technology, Dual Activating ReTargeting Technology, Bi-Specific Antibodies, Antibody-Based Technologies, Vaccine Development, Pharmaceutical Partnerships, Drug Development, Product Pipeline Advancement, Innovative Medicines
B2B, Platform
Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around MacroGenics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at MacroGenics, Inc. on 23 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.